Swiss Life Sciences Stock News

In early February 2026, Novartis reported final Phase III ALIGN data showing Vanrafia® (atrasentan) slowed kidney function decline in adults with IgA nephropathy, alongside a new long-term Actinium-225 supply agreement from Niowave to support its radioligand therapy portfolio for difficult-to-treat cancers. Together, these updates highlight Novartis’ effort to build depth in both renal disease and radiopharmaceutical oncology, reinforcing the importance of specialized therapies and secure...

As European markets navigate volatility, with the STOXX Europe 600 Index recently hitting a new high before settling nearly unchanged, investors are keenly observing economic indicators such as employment growth and GDP expansion in the eurozone. Amidst these dynamics, dividend stocks have gained attention for their potential to provide steady income; qualities like strong cash flow and a history of consistent payouts can make them appealing choices in uncertain market conditions.

The market seemed underwhelmed by the solid earnings posted by Schindler Holding AG ( VTX:SCHN ) recently. Our analysis...

Why Swisscom’s latest earnings and dividend move matter for shareholders Swisscom (SWX:SCMN) shares are in focus after the company paired its full year 2025 earnings release with a proposed CHF 26.00 per share annual dividend, drawing attention to both profitability and cash returns. See our latest analysis for Swisscom. That mix of a lower net income figure alongside solid operational progress and a proposed CHF 26.00 dividend appears to have caught the market’s eye. A 1 month share price...

In February 2026, Lindt & Sprüngli confirmed the return of its sold‑out DubaiStyle Chocolate to Canadian shelves, reintroducing the 150g bar and adding a new 40g snackable format crafted with smooth milk chocolate, pistachio filling and kadayif pastry. The launch of a portable 40g DubaiStyle bar alongside the original 150g format highlights how Lindt is using premium, culturally inspired recipes to broaden everyday indulgence occasions. We’ll now examine how expanding DubaiStyle into a new...

Temenos (SWX:TEMN) has drawn fresh attention after Peru based Mibanco selected its SaaS platform, including Temenos Core and Data Hub, to modernize core banking and support micro and small businesses across the country. See our latest analysis for Temenos. Despite winning new SaaS clients like Mibanco, Temenos has faced selling pressure, with a 30 day share price return showing an 18.75% decline and a 1 year total shareholder return indicating a 19.27% loss, suggesting sentiment has weakened...

As European markets experience volatility amidst global concerns about AI disruption and economic data releases, the pan-European STOXX Europe 600 Index has managed to reach new highs, reflecting a complex investment landscape. In such an environment, dividend stocks can offer a measure of stability and income potential for investors seeking to navigate these uncertain times.

Valiant Holding (SWX:VATN) has announced an annual dividend of CHF 6.00 per share, with an ex dividend date on May 18, 2026, a record date on May 19, and payment on May 20. See our latest analysis for Valiant Holding. The dividend announcement comes as Valiant Holding’s share price has moved to CHF 162.8, with a 30 day share price return of 4.23% and a 90 day share price return of 20.06%. The 1 year total shareholder return of 52.03% and 5 year total shareholder return of 127.20% point to...

Board overhaul puts Lonza Group (SWX:LONN) governance in focus Lonza Group (SWX:LONN) has set out a broad board refresh, nominating tech-focused leader Sami Atiya and proposing Claudia Süssmuth-Dyckerhoff as Vice-Chair while several long-serving directors prepare to step down. See our latest analysis for Lonza Group. The board refresh headlines come at a time when Lonza Group’s 1-day share price return of 1.19% and 7-day share price return of 2.21% sit against a 1-year total shareholder...

Berner Kantonalbank (SWX:BEKN) has announced an annual dividend of CHF 10.80 per share, with the payout scheduled for May 19, 2026, following the May 15 ex-date and May 18 record date. See our latest analysis for Berner Kantonalbank. The dividend announcement comes after a period of firm momentum, with a 90 day share price return of 25.7% and a 1 year total shareholder return of 43.7%, suggesting investors have recently been more positive on Berner Kantonalbank at the current CHF337.50 share...

Holcim recently launched its Women in Sustainable Construction (WISC) initiative in the UAE, aiming to advance women across technical, operational, sustainability, and leadership roles to support the country’s shift toward a resilient, low-carbon economy. This program not only aligns Holcim with sustainability priorities but also strengthens its governance profile by embedding diversity, upskilling, and mentorship into its construction value chain. Next, we’ll explore how this push to...

ABB (SWX:ABBN) is back in focus after reporting strong Q4 results, growing orders, and outlining a CHF2.0b share buyback, alongside new contract wins in power and data centre electrification. See our latest analysis for ABB. ABB’s recent Q4 update, the CHF2.0b share buyback and new electrification contracts have arrived alongside a 30 day share price return of 13.6% and a 1 year total shareholder return of 37.6%. Together these developments point to strengthening momentum rather than a short...

CEO transition and what it means for SIG Group shareholders SIG Group (SWX:SIGN) has confirmed that Mikko Keto will take over as Chief Executive Officer on 1 March 2026. This leadership change can influence how investors think about the carton packaging specialist. See our latest analysis for SIG Group. At a share price of CHF12.54, SIG Group has seen strong short term momentum with a 90 day share price return of 47.18%. However, the 1 year total shareholder return of 36.55% decline and 3...

Idorsia (SWX:IDIA) is back on investors’ radar after securing regulator alignment in the US and Europe on a streamlined Phase 3 registration program for its Fabry disease candidate, lucerastat. See our latest analysis for Idorsia. The latest lucerastat update lands after a sharp swing in sentiment, with Idorsia’s 1 year total shareholder return very large at about 5.3x. However, the year to date share price return is slightly negative and longer term total shareholder returns over 3 and 5...

Mobimo Holding (SWX:MOBN) is back in focus after reporting full year 2025 results, with higher revaluation gains, condominium sales and rental income, along with the EMWE acquisition and an unchanged dividend proposal drawing investor attention. See our latest analysis for Mobimo Holding. The recent earnings release and EMWE acquisition come after a steady recovery in sentiment, with a 10.68% 90 day share price return and a 27.04% 1 year total shareholder return suggesting that momentum has...

Roche Holding (SWX:ROG) reported that its Phase III MAJESTY study in primary membranous nephropathy met its primary endpoint with Gazyva/Gazyvaro. The result positions Gazyva/Gazyvaro as a potential first approved treatment for this rare kidney condition. The outcome may support future regulatory submissions and broaden the medicine's approved indications. For you as an investor, this sits at the heart of what Roche does: prescription medicines targeting areas with significant unmet medical...

With a median price-to-earnings (or "P/E") ratio of close to 21x in Switzerland, you could be forgiven for feeling...

Key Insights Significant insider control over Ypsomed Holding implies vested interests in company growth H. C. Michel...

Accelleron Industries has announced a major reshaping of its Board of Directors, proposing Monika Krüsi as Chairwoman and adding Mieke Van de Capelle, while two current directors step down early as part of an accelerated succession plan ahead of the 28 April 2026 AGM. This governance renewal could recalibrate how the company sets priorities in areas such as nomination, compensation, and sustainability oversight, potentially influencing its long-term direction. We’ll now examine how this...

SGS earnings event and why it matters for shareholders SGS (SWX:SGSN) recently reported full year 2025 results, with sales of CHF 6,945 million and net income of CHF 668 million. Earnings per share from continuing operations were reported at CHF 3.48 on a basic basis. See our latest analysis for SGS. The share price reacted positively to the 2025 earnings announcement, with a 1 day share price return of 2.28%. The 90 day share price return of 3.81% and 3 year total shareholder return of...

Why the Vanrafia trial is moving Novartis shares Novartis (SWX:NOVN) is back in focus after final Phase III ALIGN data showed its drug Vanrafia slowed kidney function decline in adults with IgA nephropathy, reinforcing earlier approvals and helping spark fresh investor interest. See our latest analysis for Novartis. The Vanrafia update lands on top of a strong run for Novartis, with a 30 day share price return of 8.25% and a 90 day share price return of 18.30%. This has contributed to a 1...

Recent performance and context for UBS Group shares UBS Group (SWX:UBSG) has drawn investor attention after a monthly return of about a 16% decline and a 3‑month gain of roughly 4%, set against a backdrop of mixed shorter-term price moves. See our latest analysis for UBS Group. At a share price of CHF32.10, UBS Group’s recent 1 month share price return of a 16% decline and 7 day share price return of a 5% decline contrast with a 1 year total shareholder return of 9.8% and 5 year total...

Glarner Kantonalbank's ( VTX:GLKBN ) investors are due to receive a payment of CHF1.00 per share on 30th of April. This...

It's been a good week for Swisscom AG ( VTX:SCMN ) shareholders, because the company has just released its latest...